METHAZOLAMIDE 50 MG
METHAZOLAMIDE : 50 MG · DIN 02245882 · AA PHARMA INC
Health Canada status: MARKETED
What is METHAZOLAMIDE?
METHAZOLAMIDE 50 MG contains METHAZOLAMIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02245882, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 10-May-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02245882 |
|---|---|
| Brand name | METHAZOLAMIDE |
| Generic / active ingredient | METHAZOLAMIDE : 50 MG |
| Manufacturer | AA PHARMA INC |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | S01EC05 METHAZOLAMIDE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 10-May-2011 |
How is it stored and handled?
Room Temperature
Is METHAZOLAMIDE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by AA PHARMA INC, last seen 26 May 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code S01EC05 METHAZOLAMIDE. 1 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| NEPTAZANE TABLETS 25MG | 25 MG | TABLET | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02238070 |
| NEPTAZANE TABLETS 25MG USP | 25 MG | TABLET | STORZ, DIVISION OF WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02019604 |
| NEPTAZANE TABLETS 50MG | 50 MG | TABLET | STORZ, DIVISION OF WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02022389 |
| NEPTAZANE TABLETS 50MG | 50 MG | TABLET | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02238071 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.